Michael Shetzline, CMO,SVP,Head-Res&Drug: Ironwood Pharmaceuticals IRWD Sell · Filed 23/05/24

Trade details

Type: Insider sale
Amount: $104,478.88
Shares · price: 10,324 sh · $10.12 a share
Held after: 321,131 sh
Stock: Ironwood Pharmaceuticals IRWD
Person: Michael ShetzlineCMO,SVP,Head-Res&Drug
Trade date: 23/05/22
Filed: 23/05/24
Days to filing: 2 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Ironwood Pharmaceuticals trades, last 26 weeks

What else happened in Ironwood Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/04/22~23/06/21

Michael Shetzline's recent trades

Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$377.4K
83,306 sh
$377.4K
Filed 09/23
Traded 09/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$62.3K
17,012 sh
$62.3K
Filed 02/25
Traded 02/24
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$59.3K
15,570 sh
$59.3K
Filed 02/25
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
Planned saleIronwood Pharmaceuticals
Planned sale
Ironwood Pharmaceuticals
IRWD
$138K
29,937 sh
$138K
Filed 02/20
Traded 02/23
Michael ShetzlineSVP, CMO, Head-Res&Drug
SellIronwood Pharmaceuticals
Sell
Ironwood Pharmaceuticals
IRWD
$72.6K
41,269 sh
$72.6K
Filed 25/02/12
Traded 25/02/10